US FDA approves Vertex's non-opioid painkiller
The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health regulator ...
Charlotte Observer15d
Frost & Sullivan Report Highlights SMX’s Cutting-Edge Protection for Cyber Hardware and Electronics Empowering AI
At the forefront of these efforts is its recently launched proprietary hardware protection technology, specifically designed to safeguard the critical hardware essential for the Artificial ...
Cure Today15d
FDA Approves GRAFAPEX/Fludarabine Before alloHSCT in AML and MDS
GRAFAPEX™ (treosulfan) with fludarabine is FDA-approved for AML and MDS patients undergoing alloHSCT, showing improved overall survival compared to busulfan. Common side effects include ...
Rolling Out15d
FDA unveils 8 critical safety measures for berry industry
The Food and Drug Administration (FDA) has initiated sweeping changes ... Consumers gain additional protection through improved tracking and testing requirements. Health departments anticipate ...
C&EN16d
50 new drugs received FDA approval in 2024
The FDA also gave its nod to Bristol Myers Squibb’s Cobenfy (xanomeline and trospium chloride), the first new class of antischizophrenia drug to be approved in decades. Roughly one-third of last ...
The Verge16d
The Galaxy S25 Edge is Samsung’s rumored ‘slim’ phone
He has written news, reviews, and more as a tech journalist since 2020. Samsung just teased the Galaxy S25 Edge at the end of its Unpacked event, where it announced its Galaxy S25 lineup.
The Hill16d
Nose spray to treat depression? FDA approves first-of-its-kind medicine
NEW YORK (WPIX) – The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday. Spravato is a first-of-its-kind medication to ...
Newsweek17d
FDA Approves Nasal Spray for Depression
The U.S. Food and Drug Administration (FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with treatment ...
CNN17d
FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...
The New York Times17d
Trump Administration Cancels Flights for Refugees Already Approved for Travel
The decision leaves refugees who have completed a lengthy process stranded abroad and facing extended separation from loved ones already in the U.S. By Miriam Jordan and Hamed Aleaziz Miriam ...
pix1117d
Nose spray to treat depression? FDA approves first-of-its-kind medicine
NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...
NBC New York17d
FDA approves Johnson & Johnson's nasal spray for depression as standalone treatment
Spravato's long road to rapid growth Spravato blazed a new trail in 2019 as the first new major depression treatment to win FDA approval in more than three decades. The drug is related to ketamine ...